IHM

Iguana Healthcare Management Portfolio holdings

AUM $133M
1-Year Est. Return 45.66%
This Quarter Est. Return
1 Year Est. Return
+45.66%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$151M
AUM Growth
-$23.6M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
82
New
Increased
Reduced
Closed

Top Buys

1
+$5.58M
2
+$2.1M
3
+$1.99M
4
AKCA
Akcea Therapeutics Inc
AKCA
+$1.74M
5
PBYI icon
Puma Biotechnology
PBYI
+$1.73M

Top Sells

1
+$5.61M
2
+$4.53M
3
+$3.42M
4
GKOS icon
Glaukos
GKOS
+$3.3M
5
XLRN
Acceleron Pharma
XLRN
+$2.61M

Sector Composition

1 Healthcare 82.78%
2 Energy 0.61%
3 Financials 0%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
VYGR icon
51
Voyager Therapeutics
VYGR
$275M
$830K 0.54%
50,000
+25,000
MRNS
52
DELISTED
Marinus Pharmaceuticals, Inc
MRNS
$816K 0.53%
25,000
-18,750
AKAO
53
DELISTED
Achaogen Inc
AKAO
$806K 0.52%
75,000
+45,000
ADVM icon
54
Adverum Biotechnologies
ADVM
$90M
$700K 0.46%
+20,000
OMED
55
DELISTED
OncoMed Pharmaceuticals, Inc.
OMED
$615K 0.4%
150,000
-200,000
CCXI
56
DELISTED
ChemoCentryx, Inc.
CCXI
$595K 0.39%
100,000
-175,000
SCYX icon
57
SCYNEXIS
SCYX
$31.6M
$580K 0.38%
25,000
WMGI
58
DELISTED
Wright Medical Group Inc
WMGI
$444K 0.29%
+20,000
ASXC
59
DELISTED
Asensus Surgical, Inc.
ASXC
$241K 0.16%
+9,615
OBSV
60
DELISTED
ObsEva SA Ordinary Shares
OBSV
– –
-50,000
XLRN
61
DELISTED
Acceleron Pharma
XLRN
– –
-70,000
ALXN
62
DELISTED
Alexion Pharmaceuticals
ALXN
– –
-40,000
ESRX
63
DELISTED
Express Scripts Holding Company
ESRX
– –
-25,000
AET
64
DELISTED
Aetna Inc
AET
– –
-28,500
KURA icon
65
Kura Oncology
KURA
$854M
– –
-90,000
ADAP
66
Adaptimmune Therapeutics
ADAP
$53M
– –
-25,000
ASND icon
67
Ascendis Pharma
ASND
$12.7B
– –
-30,000
CAH icon
68
Cardinal Health
CAH
$37.2B
– –
-30,000
EXEL icon
69
Exelixis
EXEL
$10.6B
– –
0
FGEN icon
70
FibroGen
FGEN
$42M
– –
-1,600
FOLD icon
71
Amicus Therapeutics
FOLD
$2.48B
– –
-60,000
GKOS icon
72
Glaukos
GKOS
$5B
– –
-100,000
INSM icon
73
Insmed
INSM
$35B
– –
-50,000
LLY icon
74
Eli Lilly
LLY
$720B
– –
-40,000
PTCT icon
75
PTC Therapeutics
PTCT
$5.24B
– –
0
1 2
3
4